SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000812796-07-000045
Filing Date
2007-05-15
Accepted
2007-05-15 16:42:02
Documents
6
Period of Report
2007-05-15

Document Format Files

Seq Description Document Type Size
1 DOR 10 QSB 1ST Q 2007 dor10q1q2007.htm 10QSB 388597
2 CEO CERTIFICATION SECTION 302 ceocert302-033107.htm EX-31.1 12893
3 CFO CERTIFICATION SECTION 302 cfocert302-1q2007.htm EX-31.2 13072
4 CEO CERTIFICATION SECTION 906 ceocert906-1q2007.htm EX-32.1 6963
5 CFO CERTIFICATION SECTION 906 cfocert906-1q2007.htm EX-32.2 7030
6 RISK FACTORS 1Q-2007 riskfactors-1q2007.htm EX-99.1 82754
  Complete submission text file 0000812796-07-000045.txt   512923
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 07854041
SIC: 2834 Pharmaceutical Preparations